PDE5A and melanoma: Owing to the potential risk in inducing melanoma and, possibly, orthostatic hypotension in PDE5 inhibitors [19], we have synthesized a series of derivatives structurally mimicking the category of sildenafil while reducing the inhibitory activity of PDE5.